Yvonne Verburgt Appointed Sr. Director Business Development At Formex, LLC

SAN DIEGO, Nov. 5, 2013 /PRNewswire/ -- Formex, LLC ("Formex"), a leader in pharmaceutical development and manufacturing, announced Yvonne Verburgt has joined Formex as a Sr. Director Business Development.

(Logo: http://photos.prnewswire.com/prnh/20130718/MM49948LOGO)

Ms. Verburgt has over 12 years of combined experience in business development and sales at contract development and manufacturing organizations.

Prior to joining Formex, LLC, Ms. Verburgt served as Sr. Director Business of Development for Pyramid Laboratories from 2012 to 2013 and as Vice President of Business Development and Marketing for Irvine Pharmaceutical Services from 2010 to 2012. Ms. Verburgt was Sr. Director of Business Development at Pharmatek from 2007 to 2010 and also had roles of increasing responsibility at Patheon, Inc., from 2000 to 2007 as Director of Business Development for Pharmaceutical Development Services ("PDS") North America. Ms. Verburgt graduated with a BS in Biology and Chemistry from the University of St. Francis.

"Yvonne brings a wealth of knowledge and expertise in business development and sales of both R&D and commercial products to Formex.  We are extremely pleased to have Yvonne join Formex as Senior Director of Business Development", stated Rudy Emmelot, President & CEO of Formex.  "Yvonne is well prepared to lead our BD efforts as Formex continues to grow and expand in capabilities and market presence."

About Formex, LLC.
Formex, LLC ("Formex"), The Formulation Experts, is a leading contract development and manufacturing organization focusing on oral and topical dosage forms.  Formex specializes in bioavailability enhancement and controlled release technologies, such as hot melt extrusion, spray drying, fluid bed processing, and liquid/semi-solid filled hard capsules.